Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.

[1]  Terry M. Therneau,et al.  Underestimation of liver-related mortality in the United States. , 2013, Gastroenterology.

[2]  V. Soriano,et al.  Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy , 2013, AIDS.

[3]  F. Bronte,et al.  P.11.9 LIVER STIFFNESS AT BASELINE PREDICTS DECOMPENSATION AND HEPATOCELLULAR CARCINOMA IN PATIENTS WITH COMPENSATED HCV CIRRHOSIS , 2013 .

[4]  C. Bombardier,et al.  Assessing Bias in Studies of Prognostic Factors , 2013, Annals of Internal Medicine.

[5]  M. Zheng,et al.  Transient elastography: a meta‐analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[6]  A. Burroughs,et al.  New therapeutic paradigm for patients with cirrhosis , 2012, Hepatology.

[7]  J. Macías,et al.  Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus‐coinfected patients with compensated liver cirrhosis , 2012, Hepatology.

[8]  F. Carrat,et al.  Noninvasive elastography‐based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis , 2012, Hepatology.

[9]  S. Ahn,et al.  The Accuracy of Noninvasive Methods in Predicting the Development of Hepatocellular Carcinoma and Hepatic Decompensation in Patients With Chronic Hepatitis B , 2012, Journal of clinical gastroenterology.

[10]  Y. N. Park,et al.  Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis , 2012, PloS one.

[11]  F. Dabis,et al.  Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. , 2012, Journal of hepatology.

[12]  Y. N. Park,et al.  Risk Assessment of Development of Hepatic Decompensation in Histologically Proven Hepatitis B Viral Cirrhosis Using Liver Stiffness Measurement , 2012, Digestion.

[13]  J. Bosch,et al.  Non invasive evaluation of portal hypertension using transient elastography. , 2012, Journal of hepatology.

[14]  S. Mehta,et al.  Transient elastography for predicting clinical outcomes in patients with chronic liver disease , 2012, Journal of viral hepatitis.

[15]  S. Lillevang,et al.  Liver stiffness and 30‐day mortality in a cohort of patients admitted to hospital , 2012, European journal of clinical investigation.

[16]  F. Tacke,et al.  Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU , 2011, Critical care.

[17]  J. Vinel,et al.  Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. , 2011, Journal of hepatology.

[18]  M. Yuen,et al.  Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg‐negative chronic hepatitis B , 2011, Journal of viral hepatitis.

[19]  Y. Paik,et al.  Risk Assessment of Esophageal Variceal Bleeding in B-Viral Liver Cirrhosis by a Liver Stiffness Measurement-Based Model , 2011, The American Journal of Gastroenterology.

[20]  Julien Vergniol,et al.  Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. , 2011, Gastroenterology.

[21]  E. Cholongitas,et al.  Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. , 2011, Journal of hepatology.

[22]  Y. N. Park,et al.  Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) , 2011, Hepatology.

[23]  Richard D Moore,et al.  1191 BASELINE LIVER STIFFNESS MEASURED BY TRANSIENT ELASTOGRAPHY IS INDEPENDENTLY ASSOCIATED WITH RISK OF END-STAGE LIVER DISEASE AND DEATH AMONG HIV/HCV CO-INFECTED ADULTS , 2011 .

[24]  S. Roman,et al.  Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests , 2010, European journal of gastroenterology & hepatology.

[25]  S. Friedman,et al.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis , 2010, Hepatology.

[26]  V. Soriano,et al.  Survival of HIV-infected patients with compensated liver cirrhosis , 2010, AIDS.

[27]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[28]  N. Kato,et al.  Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography , 2009, Hepatology.

[29]  Jonathan A C Sterne,et al.  Investigating and Dealing with Publication and Other Biases , 2008 .

[30]  M. Manos,et al.  Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment , 2007, Hepatology.

[31]  Ramon Planas,et al.  Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. , 2007, Gastroenterology.

[32]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[33]  Douglas G Altman,et al.  Systematic reviews of evaluations of prognostic variables , 2001, BMJ : British Medical Journal.

[34]  Jonathan A C Sterne,et al.  Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. , 2001, BMJ.

[35]  S G Thompson,et al.  Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. , 1996, American journal of epidemiology.

[36]  S. Pocock,et al.  Can meta-analyses be trusted? , 1991, The Lancet.

[37]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[38]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[39]  秋間 崇.  Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis , 2012 .

[40]  최은희,et al.  Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). , 2011 .

[41]  D. Forman,et al.  A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. , 2008, The American journal of gastroenterology.

[42]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.